A multicentre open label phase-IV study to evaluate safety and tolerability of inactivated vero cell derived Japanese Encephalitis vaccine in 18 to 49 year old (inclusive)healthy adult subjects in a two dose schedule.

Trial Profile

A multicentre open label phase-IV study to evaluate safety and tolerability of inactivated vero cell derived Japanese Encephalitis vaccine in 18 to 49 year old (inclusive)healthy adult subjects in a two dose schedule.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs IC 51 (Primary)
  • Indications Japanese encephalitis
  • Focus Adverse reactions
  • Sponsors Biological E Limited
  • Most Recent Events

    • 28 Feb 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 03 Dec 2012 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
    • 03 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top